IIM
CVS icon

InTrack Investment Management’s CVS Health CVS Stock Holding History

InTrack Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,857
Closed -$308K – 135
2024
Q1 		$308K Buy
3,857
+48
+1% +$3.67K 0.23% 109
2023
Q4 		$301K Sell
3,809
-35
-0.9% -$2.49K 0.23% 112
2023
Q3 		$268K Sell
3,844
-382
-9% -$27.1K 0.24% 111
2023
Q2 		$292K Sell
4,226
-365
-8% -$26K 0.24% 117
2023
Q1 		$350K Sell
4,591
-562
-11% -$47.1K 0.32% 92
2022
Q4 		$480K Buy
5,153
+923
+22% +$89.1K 0.48% 68
2022
Q3 		$403K Sell
4,230
-1,055
-20% -$104K 0.45% 72
2022
Q2 		$490K Buy
5,285
+110
+2% +$10.7K 0.5% 67
2022
Q1 		$524K Sell
5,175
-2,225
-30% -$234K 0.43% 77
2021
Q4 		$763K Sell
7,400
-102
-1% -$9.43K 0.53% 75
2021
Q3 		$680K Sell
7,502
-3,667
-33% -$307K 0.5% 73
2021
Q2 		$907K Sell
11,169
-9,300
-45% -$762K 0.71% 52
2021
Q1 		$1.54M Sell
20,469
-600
-3% -$43.7K 1.41% 22
2020
Q4 		$1.44M Buy
+21,069
New +$1.37M 1.44% 28

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

InTrack Investment Management's CVS Position: Q2 2024 in Review

InTrack Investment Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,857 shares — an estimated $308K sold.

InTrack Investment Management first reported a position in CVS in Q4 2020 and held it in 14 quarters. The position peaked at $1.54M in Q1 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • InTrack Investment Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • InTrack Investment Management sold 3,857 CVS Health shares in Q2 2024, an estimated $308K.
  • InTrack Investment Management first reported a position in CVS Health in Q4 2020 and held it in 14 quarters.
  • InTrack Investment Management's CVS Health position peaked at $1.54M in Q1 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on InTrack Investment Management's 13F filing for Q2 2024, filed 15 Jul 2024.